Aurora Cannabis (ACB) Cash & Current Investments (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Cash & Current Investments of $85.2 million for Q1 2026, down 11.31% year-on-year from $96.1 million in Q1 2025, and up 9.62% on a QoQ basis from $77.8 million in Q4 2025.

Aurora Cannabis (ACB) Cash & Current Investments (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Cash & Current Investments for 9 consecutive years, with $85.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Current Investments fell 11.31% year-over-year to $85.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.2 million (down 11.31% YoY) and the FY2026 annual result came in at $84.6 million, down 14.74% from the prior year.
  • Cash & Current Investments rose to $85.2 million in Q1 2026 per ACB's latest filing, from $77.8 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ACB reached as high as $364.0 million in Q2 2022 and fell as low as $77.8 million in Q4 2025.
  • A 5-year average of $172.2 million and a median of $146.1 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 54.29% — and 2024, when it advanced 0.8%.
  • Year by year, Cash & Current Investments stood at $207.4 million in 2022, then decreased by 27.41% to $150.6 million in 2023, then declined by 2.97% to $146.1 million in 2024, then sank by 46.77% to $77.8 million in 2025, then climbed by 9.62% to $85.2 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $85.2 million, $77.8 million, and $103.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Aurora Cannabis 155.40 Mn 70.15 Mn 21.72 Mn 85.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 85.25 Mn
Dec 31, 2025 77.77 Mn
Sep 30, 2025 103.14 Mn
Jun 30, 2025 134.26 Mn
Mar 31, 2025 96.12 Mn
Dec 31, 2024 146.10 Mn
Sep 30, 2024 127.73 Mn
Jun 30, 2024 167.73 Mn
Mar 31, 2024 101.56 Mn
Dec 31, 2023 150.58 Mn
Sep 30, 2023 143.83 Mn
Jun 30, 2023 166.39 Mn
Mar 31, 2023 189.06 Mn
Dec 31, 2022 207.45 Mn
Sep 30, 2022 302.78 Mn
Jun 30, 2022 364.00 Mn
Mar 31, 2022 362.87 Mn
Dec 31, 2021 292.85 Mn
Sep 30, 2021 329.89 Mn
Jun 30, 2021 391.18 Mn